Endologix Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Endologix Reports Second Quarter 2015 Financial Results
August 4, 2015 8:29 AM EDT
Piper Jaffray maintained an Overweight rating on Endologix (NASDAQ: ELGX), and cut the price target to $20.00 (from $21.00), following 2Q15 results. Endologix reported revenues of $39.5M, just ahead of consensus $39.4M.
Analyst Brooks West commented, "Endologix reported 2Q15 revenues of $39.5M (+8%cc) just ahead... More
August 4, 2015 7:03 AM EDT
Canaccord Genuity downgraded Endologix (NASDAQ: ELGX) from Buy to Hold with a price target of $14.00 (from $18.50).
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $14.06 yesterday.
...
More
August 3, 2015 4:08 PM EDT
Endologix (NASDAQ: ELGX) reported Q2 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $39.35 million.
For earnings history and earnings-related data on Endologix (ELGX) click here.
...
More
